Sudip Bandyopadhyay of Inditrade Capital discusses the positive outlook for the Indian pharma sector following the easing of tariff concerns. He highlights Sun Pharma’s promising developments and Glenmark’s landmark R&D deal. Bandyopadhyay also notes the expected price hike in the steel industry due to increased global demand, while emphasizing company-specific uncertainties like JSW Steel’s Bhushan Steel strategy.
Mark Mobius, pioneer of emerging markets investing, dies at 89
Mark Mobius, a pioneer of emerging markets investing, has died at 89. Known for decades at Franklin Templeton Investments, he championed opportunities across developing economies,
April 15, 2026